PLUS1
76.88
-0.05 (-0.06%)
-0.05 (-0.06%)
Upgrade to Real-Time
Afterhours (Closed)
Low
71.715
High
87.80
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.05 | -0.06% | 76.88 | 19:58:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 77.12 | 76.77 | 77.76 | 76.87 | 76.93 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 76,369 | 13,000,069 | $ 77.23 | $ 1,003,963,076 | - | 71.715 - 87.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:01 | 1 | $ 76.91 | USD |
Period:
Draw Mode:
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 194.66B | 2.53B | 2.53B | $ 48.00B | $ 5.22B | 2.77 | 28.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.48 | 3.38% | 09/14/21 | 1.34M | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 76.75 | 78.665 | 76.73 | 77.60 | 8,458,038 | 0.13 | 0.17% |
| 1 Month | 78.04 | 78.77 | 75.64 | 77.54 | 8,225,587 | -1.16 | -1.49% |
| 3 Months | 77.81 | 80.34 | 72.075 | 76.85 | 11,373,866 | -0.93 | -1.2% |
| 6 Months | 77.89 | 80.34 | 71.715 | 76.28 | 11,943,521 | -1.01 | -1.3% |
| 1 Year | 78.74 | 87.80 | 71.715 | 78.50 | 10,246,122 | -1.86 | -2.36% |
| 3 Years | 63.79 | 92.64 | 63.53 | 78.83 | 10,306,213 | 13.09 | 20.52% |
| 5 Years | 58.83 | 92.64 | 52.83 | 71.95 | 9,976,957 | 18.05 | 30.68% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States. |
